Clinical Trial Update: A Single and Repeat Dose Trial in Participants With Hepatic Impairment [Phase 1, Phase 2]

View source ↗

Summary

An early-phase clinical trial update evaluating single and repeat dosing in participants with hepatic impairment. Phase 1 and Phase 2 studies are referenced, bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment

Snippet

Sponsor: Galecto Biotech AB | Conditions: Hepatic Impairment | Phase 1, Phase 2 | Status: UNKNOWN